HomeLatest NewsFederal NewsCDC Health Advisory Regarding Reduced Availability of Oseltamivir

CDC Health Advisory Regarding Reduced Availability of Oseltamivir

Seasonal influenza activity is high across the United States. The Centers for Disease Control and Prevention (CDC) estimates that in the 2022-2023 season to date, there have been at least 13 million illnesses, 120,000 hospitalizations, and 7,300 deaths from influenza. While the Food and Drug Administration (FDA) has not indicated shortages of oseltamivir (generic or Tamiflu) in any of its forms (capsules, oral suspension), CDC has received numerous anecdotal reports of availability issues for generic oseltamivir in some locations. This may continue to occur in some communities as influenza activity continues.
In an health advisory released Dec 14, the CDC issued interim guidance for clinicians to prioritize antiviral treatment of influenza in the setting of reduced availability of oseltamivir. To read the full advisory click here.

Stay Connected

Unified Voice Newsletter

Events This Month

march

01mar11:00 am12:00 pm2024 South Dakota Telehealth Policy Update and OverviewSDAHO Webinar

04marAll Day08Rev Cycle A-ZSDHFMA Event

05mar12:00 pm1:00 pmWrite with Purpose - Take back Hours by Writing BetterSDAHO Webinar

06mar1:00 pm2:00 pmPediatric Injury Prevention: From Bare Bones to Grandiose! It All HelpsDenver Health Trauma Webinar

07marAll DayMultidisciplinary Response to Victim Services Conference


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact